Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases

    Yushan Pan, Evelyn Lilly, Ashwin N. Ananthakrishnan
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Cutaneous Manifestations in Biologically Treated Inflammatory Bowel Disease Patients: A Narrative Review Journal of clinical medicine · 2021
    2. NUDT15 R139C-Related Thiopurine Leukocytopenia Is Mediated by 6-Thioguanine Nucleotide-Independent Mechanism in Japanese Patients with Inflammatory Bowel Disease Journal of Gastroenterology · 2015
    3. Alopecia Secondary to Anti-Tumor Necrosis Factor-Alpha Therapy Anais Brasileiros de Dermatologia · 2015
    4. Frequency and Associated Factors of Hair Loss Among Patients With Inflammatory Bowel Disease World Journal of Gastroenterology · 2015
    5. Adalimumab-Induced Psoriatic Alopecia/Alopecia Areata-Like Reaction in a Patient with Crohn's Disease Dermatology Online Journal · 2015
    6. Alopecia Induced by Tumor Necrosis Factor-Alpha Antagonists: Description of 52 Cases and Disproportionality Analysis in a Nationwide Pharmacovigilance Database Rheumatology · 2014

    Related research 1

    1. Serum Zinc Concentration in Patients With Alopecia Areata Acta dermato-venereologica (Print) · 2023